WX390 Clinical Trials
3 recruitingDrug
Phase 23Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations
Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
Shanghai Jiatan Pharmatech Co., Ltd20 enrolled1 locationNCT06124963
Recruiting
Phase 1Phase 2
A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors
Solid Tumor
Shanghai Jiatan Pharmatech Co., Ltd100 enrolled1 locationNCT06117566
Recruiting
Phase 2
A Study of WX390 in Patients With Advanced Solid Tumors
Solid Tumor
Shanghai Jiatan Pharmatech Co., Ltd70 enrolled1 locationNCT06117540